Background and Purpose-Approximately 2% of the general population harbor intracranial aneurysms. The prognosis after rupture of an intracranial aneurysm is poor; 50% of the patients die as a result of the rupture. Familial occurrence of intracranial aneurysms suggests there are genetic factors involved in the development of such aneurysms. Methods-A large, consanguineous pedigree with 7 of 20 siblings affected by intracranial aneurysms was compiled and a genomewide linkage analysis on this family was performed using Illumina's single nucleotide polymorphism-based linkage panel IV, which includes 5861 single nucleotide polymorphisms. A nonparametric linkage affecteds-only approach with GENEHUNTER was used. Results-Two loci with suggestive linkage (nonparametric linkageϭ3.18) on chromosome regions 1p36 and Xp22 were identified. Additional microsatellite markers were genotyped in the 2 candidate loci and showed suggestive linkage to the locus on chromosome 1 with a nonparametric linkage of 3.18 at 1p36.11-p36.13 and significant linkage to the locus on chromosome X with a nonparametric linkage of 4.54 at Xp22.2-p22.32. Conclusions-The 2 potential loci for intracranial aneurysms, which we identified in this large Dutch family, overlap with loci that have already been identified in previous linkage studies from different populations. Identification of genes from these loci will be important for a better understanding of the disease pathogenesis.
G enetic factors are likely to be involved in the development of intracranial aneurysms (Mendelian Inheritance in Men 105800) because familial predisposition is the strongest risk factor for intracranial aneurysms and aneurysmal subarachnoid hemorrhage (SAH). 1, 2 Familial clustering of SAH is found in approximately 10% of patients with SAH, and first-degree relatives of patients with SAH have a 2.5 to 7 times greater risk of developing SAH than the general population. [3] [4] [5] [6] [7] [8] However, the segregation of SAH and intracranial aneurysms does not follow a strict Mendelian inheritance pattern in families, so the complex inheritance pattern seen is assumed to be caused by the interaction of several genes and environmental factors. 9 In complex diseases, the identification of susceptibility genes is hampered by their multigenic origin and genetic heterogeneity. 10 Variants of susceptibility genes in complex diseases are expected to be common. Not all carriers of these common variants will become affected by the disease because they may not carry all the remaining disease-associated alleles of the susceptibility genes necessary to develop the disease. 11 In addition, different combinations of genes may lead to the same phenotype in different populations. 11 To overcome these difficulties, large single families can be studied in which the disease is expected to be genetically homogeneous and the disease-associated genes will lead to the same phenotype. 12, 13 Such large single families may represent highly penetrant and rare alleles.
We previously reported on a genomewide linkage study in a large, Dutch consanguineous family. Using a recessive mode of inheritance, positive evidence of linkage on chromosome 2p13 was found with a maximum logarithm of odds (LOD) score of 3.55. 14 Because aneurysms develop over time, relatives with familial intracranial aneurysms are often screened at intervals; this yields a considerable benefit because new aneurysms are detected in approximately 10% of the relatives who previously had a negative screening result. 15 Indeed, since the completion of our genomewide linkage study in 2004, repeated screening has revealed newly developed aneurysms in 2 siblings of our family 5 years after their last negative screening. Because these newly affected siblings did not carry the risk haplotype of chromosome 2p13, our previous results of positive linkage, assuming an autosomal-recessive mode of inheritance, were no longer significant. A follow-up genomewide linkage study in this family was therefore decided on. A model-free, nonparametric linkage, affecteds-only approach was used to overcome the possible problem of complex etiology.
Subjects and Methods

Family
The family pedigree has already been described in our previous linkage study. 14 Details of the family members are shown in Table 1 and Figures 1 and 2 . The parents are first cousins and only their children are affected. DNA samples are available for the mother (I-2) and for 16 of her 20 children (see Table 1 ). The father (I-1) and the mother (I-2) of the children both died, but not from aneurysmal SAH. The father died at 62 years of age and the mother at 89 years of age. The children with aneurysmal SAH (II-6, II-9, and II-12) were defined by symptoms suggesting SAH combined with subarachnoid blood on a CT scan and a proven aneurysm on CT angiography or conventional angiography. Individual II-2 had an episode suggestive of aneurysmal SAH at the age of 36, but she died before a CT scan or angiography could be performed. Because there is no DNA sample available from this patient, she was not included in the present analysis. The children, II-11, II-15, II-17, and II-19, were diagnosed with an unruptured intracranial aneurysm identified by magnetic resonance angiography (MRA). The intracranial aneurysms in children II-11 and II-17 were identified after the end of our previous linkage study, 5 years after their last negative MRA. In our previous linkage study, 14 individual II-13 was designated as having an unruptured intracranial aneurysm identified by MRA. However, at follow-up (MRAs done 1 and 6 years after the initial positive MRA), an aneurysm could no longer be visualized. This possible falsepositive finding can be explained by the improved image quality of recent MRAs performed with increasing magnetic field strengths and leading to an improved sensitivity and, more importantly, to an improved specificity in detecting intracranial aneurysms. 16 In our present analysis, individual II-13 was therefore designated as being unaffected. In conclusion, 7 of the 16 children participating in this analysis are affected and have been diagnosed with either ruptured or unruptured intracranial aneurysms.
Genotyping
A 2-stage design was used for the linkage analysis. First, a wholegenome screen was performed in all the available individuals (nϭ17) using Illumina's single nucleotide polymorphism (SNP)-based linkage panel IV. Although we use an affecteds-only approach, it is not sufficient to only genotype the affecteds. Nonaffected family members are also genotyped to determine the phase of the affecteds. Genomic regions of potential interest were then followed up using microsatellite markers.
Genotyping of Single Nucleotide Polymorphism Markers
Illumina's SNP-based linkage panel IV includes 5861 informative SNP markers distributed evenly across the human genome with an average 14 The ID numbers of the 3 individuals that were assigned a different phenotype in our previous linkage study 14 are indicated in bold and gray. SAH? indicates unconfirmed aneurysmal SAH; SAH, aneurysmal SAH confirmed by radiological imaging; UIA, unruptured intracranial aneurysm; ACoP, posterior communicating artery; L, left; ACM, middle cerebral artery; R, right; ICA, internal carotid artery; ACoA, anterior communicating artery. distance of 0.64 cM. 17 The information content of this linkage panel is comparable to standard 5 cM short-tandem-repeat marker maps. The SNPs were genotyped using the BeadArray technology on an Illumina BeadStation following the manufacturer's protocol (www.illumina-.com). All SNPs were examined for their resulting quality and those that had a low signal or were poorly clustered were excluded (nϭ109).
Genotyping of Microsatellite Markers
In potentially interesting regions (see "Linkage Analysis" section), additional microsatellite markers were genotyped (nϭ24; see supplemental Table I , online only). The markers were selected from the Marshfield Center for Medical Genetics marker set. Genotyping for the microsatellite analysis was performed by polymerase chain reaction with detection of fluorescent polymerase chain reaction products on a 3700 DNA sequencer (Applied Biosystems) and analyzed with GeneScan and Genotyper software (Applied Biosystems). For details of genotyping with microsatellite markers, see van Belzen et al. 18 A Mendelian inheritance check was performed for both the SNP and microsatellite markers; markers with Mendelian errors were excluded (for SNPs nϭ41; for microsatellite markers nϭ0) from the linkage analysis.
Linkage Analysis
Although the consanguinity of the parents in our family suggests an autosomal-recessive mode of inheritance, other modes of inheritance cannot be ruled out. Therefore, a model-free, nonparametric linkage (NPL) analysis was performed with the linkage program GENEHUNTER (version 2.1_r2 beta) 19 using an affecteds-only approach. Using the NPL statistics, allele sharing in all possible pairs of affected individuals was determined and compared with the expected values for allele sharing. All the available 17 individuals who were genotyped were included in the analysis, and the disease status of the 7 patients with proven ruptured or unruptured intracranial aneurysms was set as affected. The other 10 were set as unknown. Because we had no DNA sample of individual II-2, who had an episode suggestive of aneurysmal SAH, she was not included in this analysis. Due to limitations of the GENEHUNTER program, we were only able to analyze microsatellite markers on the autosomal chromosomes with this program. For the analysis of the microsatellite markers on the X-chromosome, the nonparametric analysis of the MAPMAKER/SIBS program of GENEHUNTER (version 2.1_r2 beta) 20 was used. Because the SNP marker sets per Probability values corresponding to the obtained NPL scores were determined according to Kruglyak et al. 19 The threshold levels for linkage were determined according to the genomewide significance levels proposed by Kruglyak et al 19 with suggestive linkage as an NPL score Ͼ3.18 (Pϭ7.4ϫ10 -4 ), significant linkage as an NPL score Ͼ4.08 (Pϭ2.2ϫ10 -5 ), and highly significant linkage as an NPL score Ͼ4.99 (Pϭ3.0ϫ10 -7 ). Chromosomal regions with NPL scores Ͼ3.18 were considered potentially interesting.
Results
Analysis of Single Nucleotide Polymorphism Markers
Of the 5861 genotyped SNPs from Illumina's SNP-based linkage panel IV, 109 random SNPs were excluded because 31 . We have also analyzed our data assuming an autosomal-recessive and autosomal-dominant mode using different disease gene frequencies (frequency of 0.1, which is comparable with a disease prevalence of 2% and frequency of 0.01). Under these assumptions, the results remained essentially the same. The NPL scores in the previously identified locus on chromosome 2p13 14 
Analysis of Microsatellite Markers
Analysis with 2 additional microsatellite markers (Table 2) reduced the evidence of linkage to 4p14-15.1 with NPL scores varying between 0.58 (Pϭ0.28) and 0.90 (Pϭ0.18), and to 21q22.3, with NPL scores between Ϫ0.59 (Pϭ0.72) and Ϫ0.75 (Pϭ0.77).
Analysis of 10 additional microsatellite markers at the 1p36.13-36.21 locus showed a maximum NPL score of 3.18 (Pϭ7.4ϫ10 -4 ; Figure 3A ). The maximum NPL score peak occurred at markers D1S199, D1S552, and D1S2702 and the NPL-1 interval was flanked by markers D1S2826 and D1S234, which define an 18.05-cM interval. This corresponds to a 6-Mb segment from 18.6 million bp to 24.9 million bp on chromosome 1p36.11-36.13 ( Figure 3A) . The haplotypes from this region are shown in Figure 1 . Six of the 7 patients share a 6-marker diplotype (ranging from D1S2644 to D1S1622) with one chromosome inherited from the father and one from the mother, consistent with an autosomalrecessive mode of inheritance. The risk diplotype of the locus on 1p36. 13-36.21 identified by the SNP analysis also consists of one chromosome from the father and one from the mother. One patient (II-17) with an unruptured intracranial aneurysm inherited the whole haplotype from the mother but only part of the haplotype from the father. The as-yet unaffected sibling II-16 inherited the risk haplotypes from both parents. Analyzing the haplotypes shows that 2 of the patients are recombinants, which narrows down the critical region to lying between markers D1S2826 and D1S199. The number of observed recombinations on chromosome 1 exceeds the number expected for such an interval in the genome by approximately 6 times (the number expected is 0.04, whereas the number observed is 0.23). This observation is in agreement with the common phenomenon of loss of the tip of chromosome 1p and suggests that this portion of the genome is a recombination hot spot. Figure 3B shows that analysis of 9 additional microsatellite markers at the Xp22.2-22.31 locus using the MAPMAKER/ SIBS program yielded a maximum NPL score of 4.54 (Pϭ2.8ϫ10 -6 ). Marker DXS7108 has the maximum NPL score, whereas the NPL-1 interval is flanked by markers DXS6807 and DXS1224, defining a 7.73-cM interval. This corresponds to an 8 Mb segment from 4.6 million bp to 13.0 million bp on chromosome Xp22.2-p22.32. Six of the 7 patients share a 5-marker haplotype ranging from DXS6807 to DXS1224 inherited from the mother (Figure 2 ). However, patient II-15 who has an unruptured intracranial aneurysm did not inherit the risk haplotype from the mother, whereas sibling II-18, who is as-yet unaffected, did inherit this haplotype.
The presence of high linkage disequilibrium between SNP markers can cause inflation of multipoint linkage statistics, which leads to false-positive results. 21 Therefore, the 2 intervals of potential interest identified by analysis of the SNP markers on chromosome 1 and X were confirmed by analyzing additional microsatellite markers in these regions. In view of the replication of linkage with the microsatellite markers, the NPL scores of the chromosome 1 and X regions are not likely to be inflated due to the presence of linkage disequilibrium between the SNP markers analyzed.
Discussion
A follow-up linkage analysis in a large Dutch family with intracranial aneurysms is reported. In this family, the disease is expected to be genetically homogeneous in a single family, but due to the complex etiology of intracranial aneurysms, it is still possible that the disease in this family has a multigenic origin. Thus, using a model-based, parametric linkage analysis may lead to misclassifying the model. Therefore, a model-free, nonparametric linkage analysis was performed and significant linkage to 2 different loci, at 1p36.11-36.13 and Xp22.2-p22.32, was identified. In the previous linkage analysis in this family, 14 a model-based recessive mode of inheritance was used because of consanguinity of the parents of the affected children. However, this consanguinity may be a coincidence and may not lead to a recessive mode of inheritance in this family. Transmission of locus 1p36.11-36.13 does seem to follow a recessive mode of inheritance, but that of locus Xp22.2-p22.32 seems to be inherited in a dominant mode. Not all affecteds share the risk alleles at both the loci, but each affected has at least one of the risk alleles. The 2 loci may therefore compensate each other, which would indeed suggest a multigenic origin for the disease in this family. Multigenic origin for diseases in single families has been described previously, for example, in a family with celiac disease. 18 However, as long as the disease-associated mutation(s) in our family has not been identified, we cannot rule out that one of the associated loci might be spurious and that in fact in this large family, only a single diseaseassociated mutation will be found. The locus at 1p36.11-36.13 overlaps with the previously reported locus on chromosome 1p34.3-p36.13 (ANIB3; HUGO Nomenclature Committee) identified in a single North American family. 22 This family was analyzed under a dominant model and a maximum limit of detection score of 4.2 was found at marker D1S234, which appeared to be located adjacent to the marker generating the highest NPL score in our family (D1S2702). An excellent candidate gene in the overlapping region between the 2 studies is the perlecan gene, which codes for a heparan sulfate proteoglycan involved in the maintenance of the extracellular matrix of the arterial wall. It is a major component of basement membranes interacting with other basement membrane components such as laminin, collagen type IV, and other extracellular matrix molecules such as fibronectin. 23 Perlecan is believed to be involved in stabilizing macromolecules and in cell adhesion. 23 In a comprehensive case-control study with tag SNPs, we recently demonstrated SNPs in the perlecan gene to be associated with intracranial aneurysms in 3 independent populations (combined Pϭ0.0005 24 ) , further emphasizing the possible involvement of this gene in the pathogenesis of intracranial aneurysms. However, by sequencing of all the 96 exons and exon-intron boundaries of the perlecan gene, initially in 2 affected individuals of our consanguineous family and in 2 control subjects, no mutations were detected (data not shown).
The second locus on Xp22.2-p22.32 has also been previously reported in the literature. 25, 26 A nonparametric linkage analysis in 29 Japanese families, with 3 or more family members with intracranial aneurysms, identified 3 chromosomal regions, including the Xp22 locus with a maximum NPL score of 2.16. 25 Because the authors defined the boundaries of the locus by NPL scores with nominal probability values Ͻ0.05, it is not clear if this locus overlaps with our 90% support interval defined by the maximum NPL score Ϫ1. A Finnish linkage study analyzing affected sibpairs with intracranial aneurysms also found evidence for linkage to Xp22 with a maximum limit of detection score of 2.08, but after genotyping additional markers, their evidence for linkage was reduced in this region and it was not explored further. 26 A susceptibility locus for intracranial aneurysms on the X chromosome may explain the preponderance of affected women with intracranial aneurysms 1 because many genes on chromosome Xp escape X inactivation. 27 Because intracranial aneurysms are found in 2% of the population 1 and intracranial aneurysm is a complex disease, phenocopies may occur in our family. Phenocopies may influence linkage studies by lowering or by obscuring true linkage signals. Consequently, in theory, we may have left other loci than the 1p36.11-p36.13 and Xp22.2-p22.32 loci undetected in our family.
In our previous linkage study, 14 one of the siblings was assigned as being affected because MRA had revealed an unruptured intracranial aneurysm. However, in follow-up MRAs, this aneurysm could no longer be identified. The misspecification of phenotype in our previous study is especially a problem in parametric analyses and the problem can even be ameliorated in parametric analyses by providing age-based penetrance functions. The misspecification once again emphasizes that the definition of the phenotype should meet high standards of reproducibility and validity. 28 For our study, an improved specificity and sensitivity in detecting intracranial aneurysms is obtained by the improved image quality of MRAs performed with increasing magnetic field strengths. 16 To guarantee reproducibility of the intracranial aneurysm diagnosis, conventional catheter angiography was performed for confirmation of the MRA findings in case an aneurysm was detected on MRA.
The 9 loci list detected in a variety of linkage studies (loci on chromosomes 1p34.3-p36. 13 25, 26 ) confirm the genetic heterogeneity of intracranial aneurysms. Even in our single family, in which 2 loci on chromosome 1p36.11-36.13 and Xp22.2-p22.32 were identified, the disease appears to be genetically heterogeneous and multigenic. Because the locus on chromosome 1 had already been identified in another single, large family with intracranial aneurysms from North America, 22 and evidence of linkage to the locus on chromosome Xp22 was obtained in affected sibpairs and multiple families with intracranial aneurysms in Japanese and Finnish populations, 25 ,26 the 2 loci may thus be general risk factors for intracranial aneurysms in different populations.
